CH477552A - Procédé de préparation de suspension virale inactivée de virus grippaux - Google Patents

Procédé de préparation de suspension virale inactivée de virus grippaux

Info

Publication number
CH477552A
CH477552A CH1626667A CH1626667A CH477552A CH 477552 A CH477552 A CH 477552A CH 1626667 A CH1626667 A CH 1626667A CH 1626667 A CH1626667 A CH 1626667A CH 477552 A CH477552 A CH 477552A
Authority
CH
Switzerland
Prior art keywords
preparing
influenza viruses
viral suspension
inactivated viral
inactivated
Prior art date
Application number
CH1626667A
Other languages
English (en)
Inventor
Werner Georges
Original Assignee
Rhone Poulenc Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sa filed Critical Rhone Poulenc Sa
Publication of CH477552A publication Critical patent/CH477552A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CH1626667A 1966-11-21 1967-11-21 Procédé de préparation de suspension virale inactivée de virus grippaux CH477552A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR84337A FR1538322A (fr) 1966-11-21 1966-11-21 Procédé de préparation d'une suspension virale inactivée

Publications (1)

Publication Number Publication Date
CH477552A true CH477552A (fr) 1969-08-31

Family

ID=8621311

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1626667A CH477552A (fr) 1966-11-21 1967-11-21 Procédé de préparation de suspension virale inactivée de virus grippaux

Country Status (15)

Country Link
US (1) US3655871A (fr)
AT (1) AT275733B (fr)
BE (1) BE706781A (fr)
CH (1) CH477552A (fr)
DE (1) DE1617779A1 (fr)
DK (1) DK117316B (fr)
ES (1) ES347412A1 (fr)
FI (1) FI43766B (fr)
FR (1) FR1538322A (fr)
GB (1) GB1183506A (fr)
GR (1) GR33293B (fr)
IL (1) IL28977A (fr)
NL (1) NL6715369A (fr)
SE (1) SE365542B (fr)
YU (1) YU31920B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4158054A (en) 1973-10-18 1979-06-12 Duncan Flockhart & Co. Ltd. Preparation of virus sub-unit vaccines
US4000257A (en) * 1975-12-22 1976-12-28 American Cyanamid Company Process for the purification of influenza virus vaccine
US4500513A (en) * 1979-05-15 1985-02-19 Miles Laboratories, Inc. Influenza vaccine production in liquid cell culture
USRE33164E (en) * 1979-05-15 1990-02-13 Mobay Corporation Influenza vaccine production in liquid cell culture
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US4764369A (en) * 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
US4820805A (en) * 1983-07-14 1989-04-11 New York Blood Center, Inc. Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
US4841023A (en) * 1986-06-25 1989-06-20 New York Blood Center, Inc. Inactivation of viruses in labile protein-containing compositions using fatty acids
US5639461A (en) * 1994-09-30 1997-06-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Influenza machine
ATE213646T1 (de) * 1995-10-20 2002-03-15 Yissum Res Dev Co Grippe-impfstoff
AUPQ486699A0 (en) * 1999-12-23 2000-02-03 Aruba International Pty Ltd A method of treating infectious diseases
US20090017069A1 (en) 2000-06-29 2009-01-15 Lipid Sciences, Inc. SARS Vaccine Compositions and Methods of Making and Using Them
US6991727B2 (en) 2001-06-25 2006-01-31 Lipid Sciences, Inc. Hollow fiber contactor systems for removal of lipids from fluids
US20060060520A1 (en) 2001-06-25 2006-03-23 Bomberger David C Systems and methods using a solvent for the removal of lipids from fluids
US7033500B2 (en) 2001-06-25 2006-04-25 Lipid Sciences, Inc. Systems and methods using multiple solvents for the removal of lipids from fluids
US20030133829A1 (en) * 2001-12-21 2003-07-17 Baxter Healthcare Corporation Process for inactivating pathogens in a biological material
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
JP5130598B2 (ja) * 2005-09-02 2013-01-30 静岡県公立大学法人 ウイルスレセプター糖鎖認識特異性の判別方法
WO2013106548A1 (fr) 2012-01-10 2013-07-18 The Broad Institute, Inc. Procédés et cellules pour la production de vaccins viraux

Also Published As

Publication number Publication date
SE365542B (fr) 1974-03-25
FR1538322A (fr) 1968-09-06
GR33293B (el) 1967-11-21
AT275733B (de) 1969-11-10
FI43766B (fr) 1971-03-01
YU31920B (en) 1974-02-28
YU226867A (en) 1973-08-31
IL28977A (en) 1972-05-30
DK117316B (da) 1970-04-13
BE706781A (fr) 1968-05-20
NL6715369A (fr) 1968-05-22
GB1183506A (en) 1970-03-11
DE1617779A1 (de) 1972-03-23
ES347412A1 (es) 1969-01-16
US3655871A (en) 1972-04-11

Similar Documents

Publication Publication Date Title
CH477552A (fr) Procédé de préparation de suspension virale inactivée de virus grippaux
BR6465403D0 (pt) Novo processo de preparacao de 13-alquil esteroides
CH485686A (fr) Procédé de préparation de 13-alcoyl gona-pentaènes optiquement actifs
FR1517324A (fr) Procédé de préparation de sols de silice concentrés
CH442269A (fr) Procédé de préparation de dinitriles aliphatiques
BE821175A (fr) Preparation de vaccins a fragments de virus apyretogenes
DK114644B (da) Fremgangsmåde til fremstilling af antigeniske, ikke-toksiske influenzavirusunderenhedsvacciner.
FR1458183A (fr) Procédé de préparation de 1-nitro-9(dialcoylaminoalcoylamino) acridines
FR1468628A (fr) Nouveau procédé de culture de virus
CH485851A (de) Verfahren zur Herstellung von gereinigten inaktivierten Influenzaviruskonzentraten
BR6457326D0 (pt) Processo de preparacao de um derivado etinilado da 8-isoestrona
FR1369621A (fr) Procédé pour préparer les virus interférentiels
BR6353885D0 (pt) Processo de preparacao de novas lactonas derivadas do norboneno-2
FR1381310A (fr) Procédé de préparation d'une suspension concentrée de virus de la fièvre aphteuse
FR1520906A (fr) Procédé de préparation de suspensions de copolymères styrène-butadiène
FR1437361A (fr) Procédé de préparation de nouveaux éthers alcényliques de 17beta-hydroxy-androstanes
FR1495921A (fr) Procédé de préparation des composés phtalimides nu-substitués
DK116677B (da) Fremgangsmåde ved fremstilling af fåresyge-virus-vaccine.
BR6915161D0 (pt) Processo de atenuacao de raca virulenta de virus de variola de perus
FR1334952A (fr) Procédé pour la préparation de virus vivants, atténués et stabilisés
FR1371165A (fr) Procédé de stabilisation de virus morbilleux
FR1424443A (fr) Procédé perfectionné de préparation de gels de silice et de silice-alumine
FR1498560A (fr) Procédé de préparation de 17-cétostéroïdes
FR1369148A (fr) Procédé perfectionné de préparation de polyformol par polymérisation du trioxane
CH421071A (fr) Procédé de préparation de diacides aliphatiques saturés a-substitués

Legal Events

Date Code Title Description
PL Patent ceased